9th Circuit Reverses Expert Exclusion, Judgment In Immunosuppressant Cancer Case
SAN FRANCISCO — The Ninth Circuit U.S. Court of Appeals on June 2 reversed summary judgment for Teva Pharmaceuticals USA Inc. in drug-caused cancer case, ruling that the plaintiffs expert was...To view the full article, register now.
Already a subscriber? Click here to view full article